Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

被引：0

作者：

Riedl, Marc A. ^{[1
]}

Anderson, John T. ^{[2
]}

Cicardi, Marco ^{[3
]}

Li, H. Henry ^{[4
]}

Lockey, Richard F. ^{[5
]}

Longhurst, Hilary ^{[6
,7
]}

Maurer, Marcus ^{[8
]}

Lu, Peng ^{[9
]}

Hao, James ^{[9
]}

Banerji, Aleena ^{[10
]}

机构：

[1] Univ Calif San Diego, La Jolla, CA 92093 USA

[2] Clin Res Ctr Alabama, Birmingham, AL USA

[3] Univ Milan, Dept Biomed & Clin Sci, Luigi Sacco Hosp, ASST Fatebenefratelli Sacco, Milan, Italy

[4] Inst Asthma & Allergy, Chevy Chase, MD USA

[5] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA

[6] Cambridge Univ Hosp NHS Fdn Trust, Dept Immunol, Addenbrookes Hosp, Cambridge, England

[7] Barts Hlth NHS Trust, Dept Immunol, London, England

[8] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany

[9] Shire, Lexington, MA USA

[10] Harvard Med Sch, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, Boston, MA USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

112

引用

页码：AB38 / AB38

页数：1

共 50 条

[41] Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study
Riedl, Marc A.
Levy, Robyn J.
Suez, Daniel
Lockey, Richard F.
Baker, James W.
Relan, Anurag
Zuraw, Bruce L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 110 (04) : 295 - 299
[42] Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study
Hide, Michihiro
Ohsawa, Isao
Nurse, Christina
Yu, Ming
JOURNAL OF DERMATOLOGY, 2023, 50 (11) : 1381 - 1391
[43] INTERIM LONG-TERM SAFETY/EFFICACY OF RISANKIZUMAB TREATMENT IN CROHN'S DISEASE PATIENTS FROM THE OPEN-LABEL EXTENSION STUDY
Ferrante, M.
Panes, J.
Baert, F.
Louis, E.
Kaser, A.
Gustafson, D.
Hall, D.
Boecher, W. O.
Herichova, I.
Liao, X.
Wallace, K.
Kalabic, J.
D'Haens, G.
GUT, 2019, 68 : A64 - A64
[44] Long-Term Prophylaxis with Recombinant Human C1 Inhibitor in Patients with Hereditary Angioedema: Is Intramuscular Administration an Option?
Valerieva, Anna
Krusheva, Borislava
Staevska, Maria
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB56 - AB56
[45] Ongoing open-label extension study of ecallantide for the treatment of acute attacks of hereditary angioedema: interim results
MacGinnitie, A.
Pullman, W.
Patrick, H.
ALLERGY, 2010, 65 : 13 - 14
[46] Long-term Prophylaxis With C1-Inhibitor Concentrate in Patients With Hereditary Angioedema
Pedrosa, M.
Lobera, T.
Panizo, C.
Jurado, J.
Caballero, T.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2014, 24 (04) : 271 - 273
[47] Interim Results from Continuation-the Ongoing, Open-Label, Extension Study of Ecallantide for the Treatment of Acute Attacks of Hereditary Angioedema
MacGinnitie, A. J.
Pullman, W. E.
Horn, P. T.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB165 - AB165
[48] Hereditary Angioedema with Normal C1 Esterase Inhibitor Refractory to Long-Term Prophylaxis: A Case Report
Cobb, Gavin
Bernabe, Celina C.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
[49] Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience
Baynova, K.
Cimbollek, S.
Quiralte, J.
Garcia, R.
Lucena, J. M.
Luaces Lasa, E.
Lara Jimenez, M. A.
Alvarez Nieto, J.
Moreto, J.
Gonzalez-Quevedo, T.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2024, 34 (03) : 198 - 199
[50] Long-term prophylaxis with recombinant human c1 inhibitor in patients with hereditary angioedema: Extended experience with intramuscular administration
Valerieva, A.
Krusheva, B.
Staevska, M.
ALLERGY, 2018, 73 : 726 - 726

← 1 2 3 4 5 →